Home

About Us

  • Company
  • News

Blaze is an early stage company in Ann Arbor, MI, developing technology to facilitate comprehensive and standardized assessment of blood cell properties– specifically for red blood cell (RBC) hemolysis and mechanical fragility. Blaze’s testing services and products offer profiling of RBC mechanical fragility for various applications. Blaze collaborates with leading institutions to study ways of evaluating blood damage caused or treated by various medical products or being a result of disease or storage.

Read More

 

Advantages

  • Proprietary technology to measure RBC hemolysis and fragility
  • Comprehensive fragility profiling to characterize RBC health
  • Testing available on a service basis, with systems in development
  • Immediate utility in assessing drug/device safety and drug efficacy
  • Clinical potential for technology in blood banking and diagnostics